Upgrade to SI Premium - Free Trial

Truist Securities Downgrades Centessa Pharmaceuticals (CNTA) to Hold

April 13, 2026 1:49 AM
Truist Securities analyst Danielle Brill downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from Buy to Hold with a price target of $38.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades